QTI · Qt Imaging Holdings, Inc.
$2.77
+0.00 (+0.00%)
At close · Sep 2
Going-concern doubt
— cleared Aug 12, 2026
The latest filing no longer states the doubt (first flagged May 13, 2026).
View the 10-Q filed Aug 12, 2026Market Cap
$40.54M
Shares
14.64M
QTI metrics
57 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$2.77
Market cap
$40.54M
Price action
19 metricsPrice change (1W)
-14.5%
Price change (30D)
+5.3%
Price change (3M)
-37.6%
Price change (6M)
-53.8%
Price change (YTD)
-54.6%
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
67.8%
Beta
0.8
RSI (14D)
41.2
Price vs SMA 50
-13.6%
Price vs SMA 200
-46.9%
Avg volume (3M)
41,749
Relative volume
2.3
Average dollar volume
$142,036
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
14.64M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.6×
reciprocal yield 64.4%
EV / EBITDA
—
EV / EBIT
—
P / sales
1.5×
reciprocal yield 65.2%
P / book
18.1
reciprocal yield 5.5%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-50.4%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
4.9×
reciprocal yield 20.5%
EV / revenue historical average (5Y)
4.9×
reciprocal yield 20.5%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-12
Profitability
9 metricsGross margin
40.4%
Operating margin
-24.8%
Trailing 12 months
Net margin
-77.3%
Gross profit (TTM)
$10.68M
Operating profit (TTM)
−$6.57M
Net income (TTM)
−$20.42M
Trailing 12 months
Diluted EPS (TTM)
$-1.38
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+103.2%
Year over year
Net income growth YoY
—
Revenue (TTM)
$26.43M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+56.9%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-909.2%
Return on assets
-66.7%
Debt / equity
5.1
Current ratio
3.1
EBITDA (TTM)
−$6.47M
Free cash flow (TTM)
—
Quick ratio
2.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$473,000
Latest balance sheet
Cash & equivalents
$10.92M
Total assets
$30.63M
Total debt
$11.40M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$12.47M
Capital expenditures (TTM)
—
R&D (TTM)
$5.53M
SG&A (TTM)
$11.71M
Stock compensation (TTM)
$1.53M
R&D / revenue
20.9%
Stock compensation / revenue
5.8%
Ownership (13F)
3 metrics13F filers
29
13F filer change QoQ
+7
Institutional ownership
22.3%
Short interest
3 metricsShort interest
1.5%
Latest settlement · 6.9 days to cover
Days to cover
6.9d
Short-squeeze score
58 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1844505
CUSIP
746962307
13F (30d)
25 filings
25 filers
Visit website
Investor relations